Upper GI Cancer Treatment Algorithm

Panelists discuss how recent clinical trials have revolutionized treatment paradigms for gastrointestinal cancers, shaping evidence-based approaches that optimize patient outcomes through targeted therapies, immunotherapies, and multimodal treatment strategies.

Panelists discuss how they incorporate nivolumab into clinical practice, highlighting specific patient characteristics, biomarkers, and disease features that predict favorable responses to this immunotherapy agent.

Panelists discuss how multidisciplinary approaches, molecular profiling, and recent advances in targeted therapies and immunotherapy have transformed the management landscape for patients with metastatic gastric adenocarcinoma.

Panelists discuss how multidisciplinary strategies incorporating chemotherapy, targeted agents, and immunotherapy are strategically sequenced to optimize outcomes for patients with advanced metastatic gastric adenocarcinoma.

Panelists discuss how second-line treatments for gastric adenocarcinoma provide survival advantages, improved quality of life, and opportunities for personalized therapy based on molecular profiling and prior treatment response.